Triamcinolone hexacetonide/Sodium Hyaluronate

己曲安奈德/透明质酸钠

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTriamcinolone hexacetonide/Sodium Hyaluronate
Drug Alias Name透明质酸钠/己曲安奈德Triamcinolone hexacetonide and Sodium HyaluronateSodium Hyaluronate/Triamcinolone hexacetonide己曲安奈德透明质酸钠Sodium Hyaluronate and Triamcinolone hexacetonide +[7] 
ClassificationSmall molecules
Mechanisms of ActionGlucocorticoid receptor agonistsHyaluronic acid replacements
TargetsGlucocorticoid receptorHyaluronic acid
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsOsteoarthritis, Knee
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2016/01/01
Country/TerritoryCzechiaCanadaUnited States +[5] 
CombinationsYes Sodium HyaluronateTriamcinolone hexacetonide
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAnika
China Registration ClassN/A

Develop Information

Active CompaniesPendopharmAnikaPharmascience Inc +[4] 
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeH02AB08
Related LinksN/A